✦ LIBER ✦

A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction

✍ Scribed by David J. Adelstein, Cristina P. Rodriguez, Lisa A. Rybicki, Denise I. Ives, Thomas W. Rice

Book ID: 113064578
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 133 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9736-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Randomized, Placebo-Controlled

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

✍ Argiris, A.; Ghebremichael, M.; Gilbert, J.; Lee, J.-W.; Sachidanandam, K.; Kole 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 328 KB

A Phase II Trial of Docetaxel and CPT-11

A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia

✍ Jatoi, Aminah ;Tirona, Marisa Tria ;Cha, Steven S. ;Alberts, Steven R. ;Rowland, 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 86 KB

Phase II study of docetaxel for recurren

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A phase II trial of modified weekly irin

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

✍ Dae Ho Lee; Heung Tae Kim; Ji-Youn Han; Sung Young Lee; Sung Jin Yoon; Hyae Youn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

Phase II Study of Aflibercept (VEGF-Trap

Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial

✍ Przemyslaw Twardowski; Walter M. Stadler; Paul Frankel; Primo N. Lara; Christoph 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Long-term outcome of a phase II study of

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

✍ Nicholas W. Choong; Ann M. Mauer; Daniel C. Haraf; Mark K. Ferguson; Alan B. San 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 353 KB